FLR
56
-2
BXP
60
5
CB
55
2
CTSH
60
3
AKAM
50
-3
EFX
41
-5
RL
80
2
MOS
43
-5
STX
55
-2
MRK
35
2
AZO
53
3
C
62
-3
UPS
61
-3
PGR
68
3
LUV
42
-3
COST
66
3
SO
62
3
EXPD
48
-5
PCG
93
4
NOV
55
-4
FLR
56
-2
BXP
60
5
CB
55
2
CTSH
60
3
AKAM
50
-3
EFX
41
-5
RL
80
2
MOS
43
-5
STX
55
-2
MRK
35
2
AZO
53
3
C
62
-3
UPS
61
-3
PGR
68
3
LUV
42
-3
COST
66
3
SO
62
3
EXPD
48
-5
PCG
93
4
NOV
55
-4
Financhill
Back

Gold Royalty Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

GROY
Gold Royalty

Last Price:
1.28
Seasonality Move:
-2.74%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
134.73
Seasonality Move:
14.88%
Sell
23
Gold Royalty (GROY) is a Sell

Is Gold Royalty a Buy, Sell or Hold?

  • The current Gold Royalty [GROY] share price is $1.27. The Score for GROY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • GROY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GROY Stock Price Chart

What is Gold Royalty's stock price today?

  • The Gold Royalty share price today is $1.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GROY is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

GROY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.81 Sell
Chaikin Money Flow: 448418 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 1.47) Sell
Bollinger Bands (100): (1.29 - 1.45) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

GROY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.29 Sell
20-day SMA: 1.35 Sell
50-day SMA: 1.39 Sell
200-day SMA: 1.57 Sell
8-day EMA: 1.29 Sell
20-day EMA: 1.34 Sell
50-day EMA: 1.37 Sell
200-day EMA: 1.49 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Gold Royalty Earnings Growth & GROY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.01 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Gold Royalty Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):